BioAdvance
  • Home
  • About
  • Team
  • Portfolio
  • News
  • FAQ
  • Contact


News

Dec 14, 2022

By bioadvance


Aug 15, 2022

By bioadvance


Jul 13, 2022

By bioadvance


Jul 07, 2022

By bioadvance


Apr 05, 2022

By bioadvance


Mar 30, 2022

By bioadvance


Mar 15, 2022

By bioadvance


Feb 18, 2022

By bioadvance


Sep 14, 2021

By bioadvance


Dec 16, 2020

By bioadvance


  • ← Older posts

Current News

  • Annovis Bio Announces Filing of Patent Covering the Administration of Buntanetap and Its Analogues for the Treatment of Mental Illnesses
  • Strados Labs Forms Collaboration with Boehringer Ingelheim for its Idiopathic Pulmonary Fibrosis (IPF) Pilot Study
  • Annovis Bio Announces Patient Enrollment Update For Phase 3 Study of Buntanetap for the Treatment of Parkinson’s Disease
  • iVIEW announces Completion of First Patient Treatment in Phase II Clinical Study of IVIEW-1201 for the Treatment of Bacterial Conjunctivitis
  • Relmada Therapeutics Appoints Fabiana Fedeli from M&G Investments to its Board of Directors

© 2013-2023 BioAdvance. All rights reserved.